Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan

IMPORTANCE: There are emerging concerns from case reports and pharmacovigilance analyses of a possible risk of interstitial lung disease (ILD) associated with the use of factor Xa (FXa) inhibitors. OBJECTIVE: To evaluate the risk of incident ILD associated with the use of oral anticoagulants (OACs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yi-Hsin, Chao, Tze-Fan, Chen, Shao-Wei, Lee, Hsin-Fu, Chen, Wei-Min, Li, Pei-Ru, Yeh, Yung-Hsin, Kuo, Chi-Tai, See, Lai-Chu, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682427/
https://www.ncbi.nlm.nih.gov/pubmed/36413365
http://dx.doi.org/10.1001/jamanetworkopen.2022.43307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682427/
https://www.ncbi.nlm.nih.gov/pubmed/36413365
http://dx.doi.org/10.1001/jamanetworkopen.2022.43307

Ejemplares similares